Business Wire

Percona Redefines Cloud-Native Database Management with Percona Everest: the World's First Open Source Public DBaaS Alternative

Share

Percona, a global leader in enterprise-grade open source database software and services, today announced that its groundbreaking new database platform, Percona Everest, is now generally available to the public. Percona Everest is an open source, cloud-native database platform designed to deliver similar core capabilities and conveniences provided by database-as-a-service (DBaaS) offerings but without the burden of vendor lock-in and associated challenges.

Percona Everest facilitates the work of developers, QA engineers, DevOps engineers, database administrators, and anyone who could benefit from self-serve deployment and management of MySQL, PostgreSQL and MongoDB on Kubernetes. Percona Everest simplifies database management and enables database deployment standardization across multiple clouds and environments. Percona Everest helps enterprises accelerate business operations through its reliable, scalable, and secure cloud-native database infrastructure architecture.

“Percona Everest represents a paradigm shift in the management of cloud-native databases on Kubernetes,” said Ann Schlemmer, CEO at Percona. “After several years of significant growth in the public DBaaS market, organizations are pushing back against public DBaaS solutions that actively cultivate lock-in, limiting flexibility and driving up costs for customers. We developed Percona Everest to counter these issues, providing our customers with the conveniences of the leading public DBaaS offerings but without the limitations.”

As organizations look to build more products and services in the cloud, many are beginning to discover a host of hidden costs associated with popular public DBaaS offerings. Even when compared to other types of proprietary, “as-a-service” solutions, public DBaaS offerings can be particularly effective in cultivating vendor lock-in, making it exceedingly difficult for customers to maintain control over data access, database configurations, and cloud costs.

Percona Everest was designed with these very issues in mind. Unlike traditional DBaaS offerings, Percona Everest does not function as hosted infrastructure. Instead, Percona Everest allows organizations to self-serve provision and manage highly performant, open source database clusters on Kubernetes using the infrastructure they control—whether it be a cloud of their choosing, on-premises, or both. As a result, users of Percona Everest maintain control over mission-critical matters, including data access, database configuration, and costs associated with running databases in the cloud. Percona Everest extends the benefits of platform engineering to database provisioning and management.

Multi-Database, Multi-Cluster, Comprehensive Capabilities Combined with Expert Support

Percona Everest brings together the automated provisioning and management of multiple databases across different environments, all within a single, intuitive, multi-cloud user interface. By leveraging automation, users can create enterprise-ready database instances of MySQL, MongoDB, and PostgreSQL in minutes. Percona Everest enables the creation of databases pre-configured with optimal parameters and settings for available resources. Key features include:

  • Multi-Database Support: Manage various database technologies, including MySQL, MongoDB, and PostgreSQL, within a unified platform.
  • Kubernetes-Based Deployments: Run both development environments and databases on Kubernetes to automate database management and provisioning, simplifying and accelerating application development.
  • Multi-Cloud and On-Premise Deployments: Deploy databases across multiple clouds or on-premises infrastructure, including OpenShift, to ensure redundancy, high availability, and data sovereignty.
  • Private and Custom Deployments: Maintain the privacy and security of the database environment with private deployments, enabling customization of every aspect of the database setup.
  • Intuitive User Interface: Simplify administrative tasks with the ability to add and manage storage locations, monitoring endpoints, storage classes, and other default configurations from a central interface.
  • Comprehensive Monitoring: Gain insights into performance metrics, query analysis, and more with the integrated Percona Monitoring and Management (PMM) tool.
  • Single Sign-On (SSO) Integration: Centralize user authentication, simplify access, and enhance security across your database deployments.
  • Disaster Recovery: Maintain business continuity with tools that support high availability and disaster recovery.

Percona offers enterprise-grade support for Percona Everest users and all their database deployments. In keeping with Percona’s spirit of flexibility and choice, Percona Everest users can opt to manage their cloud-native database platform independently or with the help and support of Percona's team of database performance experts. The Percona team is always available to support any organization making the transition to Kubernetes-based deployments.

Early Adopters Benefit From, Build With Percona Everest

Percona introduced Everest to a select group of customers earlier this year. Adoption has been growing steadily, and users are extolling the platform’s benefits.

“In designing our DBaaS service for customers, we knew that companies would want the benefits of technologies like Kubernetes and cloud-native services while avoiding the costly and extremely challenging aspects of running this themselves,” said Handoyo Sutanto, CEO and Co-Founder of Lyrid. “With Percona Everest, we have built a fully managed, flexible database service for our customers which we can provide without the levels of lock-in and expense associated with other cloud providers.”

Gifford Holmquist from Samaritan's Purse stated, "We migrated to Percona Everest from the Public Cloud in order to control our own data, reduce costs, and avoid vendor lock-in wherever possible. We’ve met each of these objectives, and we’re very happy with the move. It's been a very successful decision.”

Learn more about Percona Everest by visiting the Documentation section of the Percona website.

About Percona
Percona is a world-class open source database software, support, and services company. The organization is dedicated to helping businesses ensure their databases — and the applications that depend on them — are secure, compliant, performant, and highly available. Through a unique combination of database expertise and enterprise-grade open source software, Percona empowers organizations with the freedom to choose, the freedom to create, and the freedom to innovate with speed as they grow. For more information, visit www.percona.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240917948450/en/

Contacts

Media Contact:
Jacob Manchester
Scratch Marketing + Media for Percona
jacob@scratchmm.com
401-636-7757

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Coincheck Group N.V. to Announce Third Quarter 2025 Results on February 12, 202531.1.2025 15:30:00 EET | Press release

Coincheck Group N.V. (the “Company”) (Nasdaq: CNCK), the holding company for Coincheck, Inc, a leading Japanese crypto exchange, today announced that the Company will release its third quarter 2025 financial results on Wednesday, February 12, 2025. The Company will host a conference call to discuss third quarter 2025 financial results at 5:00 pm ET that same day. Hosting the call will be Oki Matsumoto, Executive Chairman, Gary Simanson, Chief Executive Officer, and Jason Sandberg, Chief Financial Officer. The call will be webcast live from the Company's website at www.coincheckgroup.com. A replay will be available on the Company’s investor relations website following the call. The conference call can also be accessed over the phone by dialing (877) 407-4018 or (201) 689-8471; the Conference ID is 13751285. About Coincheck Group N.V. Headquartered in the Netherlands, Coincheck Group N.V. (NASDAQ: CNCK) is a public limited liability company and the holding company for Coincheck, Inc. Coi

Datopotamab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer31.1.2025 15:00:00 EET | Press release

Datopotamab deruxtecan (Dato-DXd) has been recommended for approval in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received endocrine therapy and at least one line of chemotherapy in the advanced setting. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE:45680) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast01 phase 3 trial published in the Journal of Clinical Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast01, datopot

REPLY: Coding and Cybersecurity, Registration Is Now Open for the Reply Hack The Code Challenge 202531.1.2025 13:42:00 EET | Press release

Reply has announced the opening of registrations for the ReplyHackThe Code Challenge 2025, the leading online team coding competition, which will take place on March 12th 2025. This year's challenge will combine programming and cybersecurity for the first time, offering participants the opportunity to tackle algorithmic problems and cybersecurity challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250131992792/en/ Reply has announced the opening of registrations for the Reply Hack The Code Challenge 2025, the leading online team coding competition, which will take place on March 12th 2025. This year's challenge will combine programming and cybersecurity for the first time, offering participants the opportunity to tackle algorithmic problems and cybersecurity challenges. (Photo: Business Wire) The competition follows the format of previous events, with two parallel challenges: the Standard Edition, aimed at university

GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand31.1.2025 10:00:00 EET | Press release

GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on the grounds of the existing site will enable 25 million more patient doses per year of contrast media by the end of 2027, helping address growing global demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250130241464/en/ GE HealthCare’s contrast media manufacturing site in Cork (Photo: Business Wire) Contrast media are injectable diagnostic imaging agents used to enhance visualization of organs, blood vessels and tissues during medical imaging. Global demand for iodine-based contrast media, used in X-Ray, Computed Tomography (CT) and Interventional procedures is expected to double in the next decade, driven by ageing populations and the increasing global prevalence of chronic disorders. In 2024, the Carrigtohill facility, a

Vertex Announces CASGEVY ® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England31.1.2025 09:00:00 EET | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel). The reimbursement agreement comes as the National Institute for Health and Care Excellence (NICE) issues positive guidance recommending CASGEVY’s use in the NHS. It means that eligible SCD patients in England now have access to the therapy following the prior agreement for transfusion-dependent beta thalassemia (TDT) patients announced last August. “Today is an important day for the sickle cell community who have gone too long without treatments that address the underlying cause of their devastating disease,” said Ludovic Fenaux, Senior Vice President, Vertex International. “We are pleased to have reached this new agreement that ensures both eligible SCD and TDT patients can now be treated with CASGEVY, recognizing the value a one-time treatment can provide to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye